Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Electrocore Llc (ECOR)
NASDAQ:ECOR
Holding ECOR?
Track your performance easily
ECOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.90 - $8.08
Previous Close$6
Volume1.36K
Average Volume (3M)9.36K
Market Cap
$39.36M
Enterprise Value$28.45M
Total Cash (Recent Filing)$14.20M
Total Debt (Recent Filing)$3.97M
Price to Earnings (P/E)―
Beta0.40
Next Earnings
Nov 14, 2024EPS Estimate
-$0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.19
Shares Outstanding6,446,866
10 Day Avg. Volume16,680
30 Day Avg. Volume9,357
Standard Deviation0.31
R-Squared0.01
Alpha-0.00032
Financial Highlights & Ratios
Price to Book (P/B)3.37
Price to Sales (P/S)1.88
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.34
Enterprise Value/Gross Profit2.15
Enterprise Value/Ebitda-2.15
Forecast
1Y Price Target
$15.00Price Target Upside145.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Electrocore News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ECOR FAQ
What was Electrocore Llc’s price range in the past 12 months?
Electrocore Llc lowest stock price was $4.90 and its highest was $8.08 in the past 12 months.
What is Electrocore Llc’s market cap?
Currently, no data Available
When is Electrocore Llc’s upcoming earnings report date?
Electrocore Llc’s upcoming earnings report date is Nov 14, 2024 which is in 57 days.
How were Electrocore Llc’s earnings last quarter?
Electrocore Llc released its earnings results on Aug 07, 2024. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.43 by $0.05.
Is Electrocore Llc overvalued?
According to Wall Street analysts Electrocore Llc’s price is currently Undervalued.
Does Electrocore Llc pay dividends?
Electrocore Llc does not currently pay dividends.
What is Electrocore Llc’s EPS estimate?
Electrocore Llc’s EPS estimate is -$0.31.
How many shares outstanding does Electrocore Llc have?
Electrocore Llc has 6,446,866 shares outstanding.
What happened to Electrocore Llc’s price movement after its last earnings report?
Electrocore Llc reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.43. Following the earnings report the stock price went down -1.311%.
Which hedge fund is a major shareholder of Electrocore Llc?
Currently, no hedge funds are holding shares in ECOR
---
Electrocore Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (145.70% Upside)
$15.00 (145.70% Upside)
Insider Transactions
Bought Shares
Worth $30.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
6.19%
12-Months-Change
Fundamentals
Return on Equity
-153.49%
Trailing 12-Months
Asset Growth
57.19%
Trailing 12-Months
Company Description
Electrocore Llc
electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.
---
ECOR Earnings Call
Q2 2024
0:00 / 0:00
---
ECOR Stock 12 Month Forecast
Average Price Target
$15.00
▲(145.70% Upside)
Technical Analysis
BioSig Technologies
―
BioNano Genomics
―
Assertio Therapeutics
―
Kintara Therapeutics
―
Best Analysts Covering ECOR
1 Year
1 Year Success Rate
6/16 ratings generated profit
1 Year Average Return
-8.51%
reiterated a buy rating last month
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -8.51% per trade.
---